ArticleActa pharmaceutica Sinica. B2022

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.

Dandan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.